GP 1a is a potent agonist of cannabinoid receptor 2 (CB2) (EC50=7.1), as shown in cAMP, GTPgammaS and beta-arrestin recruitment assays. GP 1a is approximately 30-fold more selective for CB2 receptors than CB1 receptors and increases P-ERK1/2 expression in HL-60 cells in vitro. GP 1a is beneficial for skin wound healing. GP 1a inhibits inflammation and fibrogenesis while promoting epithelial re-formation.
Molecular Weight:
441.35
Purity:
99.44%
CAS Number:
[511532-96-0]
Formula:
C23H22Cl2N4O
Target:
ERK|||Cannabinoid Receptor
T41231
* VAT and and shipping costs not included. Errors and price changes excepted
